Abstract: Uses for the compound sodium mercaptoethanesulphonate, commonly known as mesna are disclosed. The appropriate periodic administration of said compound to a patient or the addition of the compound to a preservation solution for a donor organ can prevent reperfusion injury. Likewise, the prescribed periodic administration of mesna to a patient whose peritoneum is about to be violated will aid in avoiding peritonitis.
Type:
Grant
Filed:
June 7, 1995
Date of Patent:
August 26, 1997
Assignee:
Medical Research Foundation and Infrastructure Development for Health Services--Nahariya Hospital Branch